Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-01-02 @ 2:09 AM
Study NCT ID:
NCT00485732
Status:
COMPLETED
Last Update Posted:
2018-07-20
First Post:
2007-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-11
Start Date Type:
None
Primary Completion Date:
2008-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-12
First Submit QC Date:
None
Study First Post Date:
2007-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-11-12
Results First Submit QC Date:
None
Results First Post Date:
2009-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-24
Last Update Post Date:
2018-07-20
Last Update Post Date Type:
ACTUAL